Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic

Vaccine

Volumn 27, Issue 1, 2009, Pages 146-151

  Simani, Omphile E ^a   Leroux Roels, Geert ^b   François, Guido ^c   Burnett, Rosemary J ^a   Meheus, André ^c   Mphahlele, M Jeffrey ^a  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Africa; Hepatitis B vaccine; Seroprotection; South Africa

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CHILD; FEMALE; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROCONVERSION; SEROPROTECTION; SOUTH AFRICA;

AMBULATORY CARE FACILITIES; CROSS-SECTIONAL STUDIES; DNA, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT; INFANT, NEWBORN; PREVALENCE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; VACCINATION;

EID: 56949108483     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.004     Document Type: Article

References (27)

1. Burnett R.J., François G., Kew M.E., Leroux-Roels G., Meheus A., Hoosen A.A., et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int. 25 (2005) 1-12
2. Mphahlele M.J., and François G. Editorial report: joining forces against infectious diseases in sub-Saharan Africa. S. Afr. J. Epidemiol. Infect. 23 1 (2008) 2-3
3. François G., Dochez C., Mphahlele M.J., Burnett R.G., Van Hal G., and Meheus A. Hepatitis B vaccination in Africa: mission accomplished?. S. Afr. J. Epidemiol. Infect. 23 1 (2008) 24-28
4. Whittle H.C., Maine N., Pilkington J., Mendy M., Fortuin M., Bunn J., et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 345 8957 (1995) 1089-1092
5. Tsebe K.V., Burnett R.J., Hlungwani N.P., Sibara M.M., Venter P.A., and Mphahlele M.J. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year olds. Vaccine 19 (2001) 3919-3926
6. Arrazola M.P., de Juanes J.R., Ramos A.J., Aragón A.J., and García de Codes A. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J. Med. Virol. 45 (1995) 339-341
7. Alberti A., Clumeck N., Collins S., Gerlich W., Lundgren J., Palù G., et al. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J. Hepatol. 42 (2005) 615-624
8. UNAIDS. AIDS epidemic update. Geneva: UNAIDS. December 2007 website, May 10, 2008. http://www.unaids.org; 2007.
9. Davis L.G., Weber D.J., and Lemon S.M. Horizontal transmission of hepatitis virus. Lancet 1 8643 (1989) 889-893
10. Dabis F., and Ekpini E.R. HIV-1/AIDS and maternal and child health in Africa. Lancet 359 9323 (2002) 2097-2104
11. Moss W.J., Clements C.J., and Halsey N.A. Immunisation of children at risk of infection with human immunodeficiency virus. Bull. World Health Org. 81 1 (2003) 61-70
12. Thio C.L. Hepatitis B in human immunodeficiency virus infected patients: epidemiology, natural history, and treatment. Semin. Liver Dis. 23 2 (2003) 125-136
13. Zijenah L.S., Humphrey J., Nathoo K., Malabu L., Zvandasara P., Mahohva A., et al. Evaluation of the prototype Roche DNA amplification kit incorporating the new SSK145 and SKCC1B primers in detection of human immunodeficiency virus type 1 DNA in Zimbabwe. J. Clin. Microbiol. 37 11 (1999) 3569-3571
14. Benjamin Jr. D.K., Miller W.C., Fiscus S.A., Benjamin D.K., Morse M., Valentine M., et al. Rational testing of the HIV-exposed infants. Paediatrics 108 1 (2000) e3
15. Cassol S., Salas T., Arella M., Neumann P., Schechter M.T., and O'Shaughnessy M.V. Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction. J. Clin. Microbiol. 29 4 (1991) 667-671
16. Cassol S., Salas T., Gill M.I., Montpetit M., Rudnik J., Sy C.T., et al. Stability of dried blood spot specimens for detection of human immunodeficiency virus DNA by the polymerase chain reaction. J. Clin. Microbiol. 30 12 (1992) 3039-3042
17. Beck I.A., Drennan K.D., Melvin A.J., Mahon K.M., Herz A.M., Alarcon J., et al. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J. Clin. Microbiol. 39 1 (2001) 29-33
18. Mphahlele M.J., Lukhwareni A., Burnett R.J., Moropeng L.M., and Ngobeni J.M. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J. Clin. Virol. 35 (2006) 14-20
19. Schoub B.D., Matai U., Singh B., Blackburn N.K., and Levin J.B. Universal immunization of infants with low doses of low-cost, plasma derived hepatitis B vaccine in South Africa. Bull. World Health Org. 80 4 (2002) 277-281
20. Bruguera M., Cremandes M., Salinas R., Costa J., Grau M., and Sans J. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J. Clin. Gastroenterol. 14 I (1992) 27-30
21. Fortuin M., Chortard J., Jack A.D., Main N.P., Mendy M., Hall A.J., et al. Efficacy of hepatitis B vaccine in the Gambian expanded program on immunization. Lancet 341 (1993) 1129-1131
22. Aspinall S., and Kocks D.J. Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation. S. Afr. J. Med. 88 1 (1998) 36-39
23. Zuccotti G.V., Riva E., Flumine P., Locatelli V., Fiocchi A., Tordato G., et al. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J. Pediatr. 125 1 (1994) 70-72
24. Rey D., Kranz V., Partisani M., Schmitt M.P., Meyer P., Libbrecht E., et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1. Vaccine 18 (2000) 1161-1165
25. Obaro S.K., Pugatch D., and Luzuriaga K. Immunogenicity and efficacy of childhood vaccines in HIV-infected children. Lancet Infect. Dis. 4 (2004) 510-518
26. Poland G.A., and Jacobson R.M. Clinical practice: prevention of hepatitis B with hepatitis B vaccine. N. Engl. J. Med. 351 (2004) 2832-2838
27. Fonseca M.O., Pang L.W., de Paula Cavalheiro N., Barone A.A., and Heloisa Lopes M. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 23 22 (2005) 2902-2908